![Doctor Salomón Menjón: «Cada vez encontramos más casos de cáncer de mama en mujeres jóvenes» | Ideal Doctor Salomón Menjón: «Cada vez encontramos más casos de cáncer de mama en mujeres jóvenes» | Ideal](https://s1.ppllstatics.com/ideal/www/multimedia/201811/29/media/cortadas/MENJON-kwsE-U60172653706090B-624x385@Ideal.jpg)
Doctor Salomón Menjón: «Cada vez encontramos más casos de cáncer de mama en mujeres jóvenes» | Ideal
![Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care - Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care -](https://onlinelibrary.wiley.com/cms/asset/d6953734-a396-4af0-a383-9c343147151a/ecc.2013.22.issue-4.cover.jpg?trick=1676094985462)
Incidence of chemotherapy‐induced neutropenia and current practice of prophylaxis with granulocyte colony‐stimulating factors in cancer patients in Spain: a prospective, observational study - Jolis - 2013 - European Journal of Cancer Care -
![Día internacional de la lucha contra el cáncer de mama Salomón Menjón: "La vida sana y activa es la mejor vacuna para prevenir el cáncer" Día internacional de la lucha contra el cáncer de mama Salomón Menjón: "La vida sana y activa es la mejor vacuna para prevenir el cáncer"](https://www.diariodesevilla.es/2020/10/16/salud/doctor-Menjon-Clinica-Vithas_1510959545_126905342_1200x675.jpg)
Día internacional de la lucha contra el cáncer de mama Salomón Menjón: "La vida sana y activa es la mejor vacuna para prevenir el cáncer"
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) - Annals of Oncology
![PDF) Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate? PDF) Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?](https://i1.rgstatic.net/publication/322082464_Incidence_of_neutropenia_and_use_of_granulocyte_colony-stimulating_factors_in_multiple_myeloma_is_current_clinical_practice_adequate/links/5a43a2be458515f6b052babe/largepreview.png)